Champions Oncology, Inc. (CSBR)
5.115
+0.10
(+1.89%)
USD |
NASDAQ |
Aug 28, 11:59
Champions Oncology Debt to Equity Ratio : 1.167 for April 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| April 30, 2026 | 1.167 |
| January 31, 2026 | 1.167 |
| October 31, 2025 | 1.298 |
| July 31, 2025 | 1.691 |
| April 30, 2025 | 1.677 |
| January 31, 2025 | 1.224 |
| October 31, 2024 | 10.38 |
| July 31, 2024 | -22.41 |
| April 30, 2024 | -3.904 |
| January 31, 2024 | -3.762 |
| October 31, 2023 | 86.56 |
| July 31, 2023 | 4.388 |
| April 30, 2023 | 1.855 |
| January 31, 2023 | 1.255 |
| October 31, 2022 | 0.9774 |
| July 31, 2022 | 1.027 |
| April 30, 2022 | 1.041 |
| January 31, 2022 | 1.043 |
| October 31, 2021 | 1.172 |
| July 31, 2021 | 1.261 |
| April 30, 2021 | 1.292 |
| January 31, 2021 | 0.8168 |
| October 31, 2020 | 0.951 |
| July 31, 2020 | 1.203 |
| April 30, 2020 | 0.7449 |
| Date | Value |
|---|---|
| January 31, 2020 | 1.249 |
| October 31, 2019 | 1.849 |
| July 31, 2019 | 2.326 |
| April 30, 2019 | 0.0071 |
| January 31, 2019 | 0.0964 |
| October 31, 2018 | 0.119 |
| July 31, 2018 | 0.4734 |
| April 30, 2018 | 14.00 |
| January 31, 2018 | 0.1038 |
| October 31, 2017 | 0.1475 |
| July 31, 2017 | 0.20 |
| April 30, 2017 | 0.1575 |
| January 31, 2017 | 0.0333 |
| October 31, 2016 | 0.0228 |
| July 31, 2016 | 0.0246 |
| April 30, 2016 | 0.3487 |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | -0.4826 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
| January 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Medpace Holdings, Inc. | 0.3322 |
| Avantor, Inc. | 0.6568 |
| Personalis, Inc. | 0.1616 |
| Adaptive Biotechnologies Corp. | 2.872 |
| 10X Genomics, Inc. | 0.0954 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 26.99M |
| Total Liabilities (Quarterly) | 22.92M |
| Shareholders Equity (Quarterly) | 3.939M |
| Current Ratio | 0.9647 |
| Net Debt Paydown Yield | 0.51% |